Business Context and Reporting Period
This Form 8-K is a current report filed by Tharimmune, Inc. (trading symbol: THAR) on August 7, 2025, covering events occurring on August 4 and August 5, 2025. The registrant is a Delaware corporation and an emerging growth company headquartered in Red Bank, New Jersey.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
The primary material change reported is the appointment of Nancy Davis as a member of the Board of Directors, effective August 4, 2025. Ms. Davis will serve a term expiring at the 2026 annual meeting of stockholders. Her annual compensation will align with that of other non-employee directors. No related party transactions or special arrangements regarding her selection were disclosed.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding financial guidance, future outlook, specific risks, contingencies, or unusual items. The document serves solely to disclose the director appointment and reference a press release issued on August 5, 2025.
Investor Verification Checklist
- Verify the biographical background and qualifications of the newly appointed director, Nancy Davis.
- Confirm the total number of directors on the board following this appointment.
- Review the attached press release (Exhibit 99.1) for additional context on the board's strategic direction.
- Check subsequent filings for any updates to the board composition or related compensation agreements.